DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?

Pathology and Oncology Research

Volumn 5, Issue 3, 1999, Pages 171-178

  Larsen, Annette K ^a   Gobert, Céline ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Antitumor agents; Multifunctional proteins; Oncogenesis; Topoisomerase I

Indexed keywords

CAMPTOTHECIN; DNA; DNA TOPOISOMERASE; PROTEIN P53;

CARCINOGENESIS; COMPLEX FORMATION; DNA RECOMBINATION; DNA STRAND BREAKAGE; EMBRYO DEVELOPMENT; ENZYME KINETICS; HUMAN; PHOSPHORYLATION; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032759443     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1053/paor.1999.0209     Document Type: Article

References (85)

1. Rossi F, Labourier E, Forne T. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature. 381:1996;80-82.
2. Wang J C. Interaction between DNA and an Escherichia coli protein omega. J Mol Biol. 14:1971;523-533.
3. Champoux J J, Dulbecco R. An activity from mammalian cells that untwists superhelical DNA; a possible swivel for DNA replication. Proc Natl Acad Sci USA. 69:1972;143-146.
4. Pulleyblank D E, Morgan A R. Partial purification of Omega protein from calf thymus. Biochemistry. 14:1975;5205-5209.
5. Durnford J M, Champoux J J. The DNA untwisting enzyme from Saccharomyces cerevisiae. Partial purification and characterization. J Biol Chem. 253:1978;1086-1089.
6. Javaherian K, Tse Y C, Vega J. Drosophila topoisomerase I: isolation, purification and characterization. Nucleic Acids Res. 10:1982;6945-6955.
7. Liu L F. HeLa toposiomerase I. Methods Enzymol. 100:1983;133-137.
8. Riou G F, Gabillot M, Douc-Rasy S. A type I DNA topoisomerase from Trypanosoma cruzi. Eur J Biochem. 134:1983;479-484.
9. Shuman S, Moss B. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci USA. 84:1987;7478-7482.
10. Wallis J W, Chrebet G, Brodsky G. A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell. 58:1989;409-419.
11. Hanai R, Caron P R, Wang J C. Human TOP3: a single-copy gene encoding DNA topoisomerase III. Proc Natl Acad Sci USA. 93:1996;3653-3657.
12. Stewart L, Ireton G C, Parker L H. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I. J Biol Chem. 271:1996;7593-7601.
13. Redinbo M R, Stewart L, Kuhn P. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science. 279:1998;504-513.
14. Alsner J, Svejstrup J Q, Kjeldsen E. Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. J Biol Chem. 26:1992;2408-2411.
15. Labourier E, Rossi F, Gallouzi I E. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor. Nucleic Acids Res. 26:1998;2955-2962.
16. Rossi F, Labourier E, Gallouzi I E. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity. Nucleic Acids Res. 26:1998;2963-2970.
17. Juan C C, Hwang J, Liu A A. Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2. Proc Natl Acad Sci USA. 85:1988;8910-8913.
18. Kunze N, Yang G, Dolberg M. Structure of the human type I DNA topoisomerase gene. J Biol Chem. 266:1991;9610-9616.
19. Kunze N, Klein M, Richter A. Structural characterization of the human DNA topoisomerase I gene promoter. Eur J Biochem. 194:1990;323-330.
20. Heiland S, Knippers R, Kunze N. The promoter region of the human type-I DNA-topoisomerase gene. Protein-binding sites and sequences involved in transcriptional regulation. Eur J Biochem. 21:1993;813-822.
21. Hwong C L, Chen C Y, Shang H F. Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation. J Biol Chem. 268:1993;18982-18986.
22. Kaufmann S H, Charron M, Burke P J. Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo. Cancer Res. 55:1995;1255-1260.
23. Romig H, Richter A. Expression of the topoisomerase I gene in serum stimulated human fibroblasts. Biochim Biophys Acta. 1048:1990;274-280.
24. Desai S D, Liu L F, Vazquez-Abad D. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin. J Biol Chem. 272:1997;24159-24164.
25. Heck M M, Hittelman W N. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA. 85:1988;1086-1090.
26. Baker S D, Wadkins R M, Stewart C F. Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy. Cytometry. 19:1995;134-145.
27. Bronstein I B, Vorobyev S, Timofeev A. Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies. Oncol Res. 8:1996;17-25.
28. Muller M T, Pfund W P, Mehta V B. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J. 4:1985;1237-1243.
29. Hirano T, Konoha G, Toda T. Essential roles of the RNA polymerase I largest subunit and DNA topoisomerases in the formation of fission yeast nucleolus. J Cell Biol. 108:1989;243-253.
30. Meyer K N, Kjeldsen E, Straub T. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J Cell Biol. 136:1997;775-788.
31. Uemura T, Yanagida M. Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J. 3:1984;1737-1744.
32. Thrash C, Bankier A T, Barell B G. Cloning, characterization and sequence of the yeast topoisomerase I gene. Proc Natl Acad Sci USA. 82:1985;4374-4378.
33. Kim R A, Wang J C. Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiae. J Mol Biol. 208:1989;257-267.
34. Di Mauro E G, Camilloni E G, Verdone L. DNA topoisomerase I controls the kinetics of promoter activation and DNA topology in Saccharomyces cerevisiae. Mol Cell Biol. 13:1993;6702-6710.
35. Lee M P, Brown S D, Chen A. DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci USA. 90:1993;6656-6660.
36. Morham S G, Kluckman K D, Voulomanos N. Targeted disruption of the mouse topoisomerase I gene by camptothecin selection. Mol Cell Biol. 16:1996;6804-6809.
37. Yang L, Wold M S, Li J J. Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci USA. 84:1987;950-954.
38. Gilmour D S, Pflugfelder G, Wang J C. Topoisomerase I interacts with transcribed regions in Drosophila cells. Cell. 44:1986;401-407.
39. Garg L C, Di Angelo S, Jacob S T. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Proc Natl Acad Sci USA. 84:1987;3185-3188.
40. Merino A, Madden K R, Lane W S. DNA topoisomerase I is involved in both repression and activation of transcription. Nature. 365:1993;227-232.
41. Shykind B M, Kim J, Stewart L. Topoisomerase I enhances TFIID-TFIIA complex assembly during activaton of transcription. Genes Dev. 11:1997;397-407.
42. Kretzschmar M, Meisternst M, Roeder R G. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc Natl Acad Sci USA. 90:1993;11508-11512.
43. Bullock P, Champoux J J, Botchan M. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science. 230:1985;954-958.
44. Cheng C, Kussie P, Pavletich N. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell. 92:1998;841-850.
45. Zhu J, Schiestl R H. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae. Mol Cell Biol. 16:1996;1805-1812.
46. Bullock P, Forrester W, Botchan M. DNA sequence studies of simian virus 40 chromosomal excision and integration in rat cells. J Mol Biol. 174:1984;55-84.
47. Hino O, Ohtake K, Rogler C E. Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration. J Virol. 63:1989;2638-2643.
48. Wang H P, Rogler C E. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J Virol. 65:1991;2381-2392.
49. Anderson R D, Berger N A. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res. 309:1994;109-142.
50. Lanza A, Tornaletti S, Rodolfo C. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage. J Biol Chem. 271:1996;6978-6986.
51. Pourquier P, Pilon A A, Kohlhagen G. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J Biol Chem. 272:1997;26441-26447.
52. Rosenstein B S, Subramanian D, Muller M T. The involvement of topoisomerase I in the induction of DNA-protein crosslinks and DNA single-strand breaks in cells of ultraviolet-irradiated human and frog cell lines. Radiat Res. 148:1997;575-579.
53. Subramanian D, Rosenstein B S, Muller M T. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair. Cancer Res. 58:1998;976-984.
54. Vichi P, Coin F, Renaud J P. Cisplatin and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J. 16:1997;7444-7456.
55. Castano I B, Brzoska P M, Sadoff B U. Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase I in Saccharomyces cerevisiae. Genes Dev. 10:1996;2564-2576.
56. Kimura K, Hirano T. ATP-dependent positive supercoiling of DNA by 13S condensin: a biochemical implication for chromosome condensation. Cell. 90:1997;625-634.
57. Durban E, Goodenough M, Mills J. Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. EMBO J. 4:1985;2921-2926.
58. Kaiserman H B, Ingebritsen T S, Benbow R M. Regulation of Xenopus laevis DNA topoisomerase I activity by phosphorylation in vitro. Biochemistry. 27:1988;3216-3222.
59. Samuels D S, Shimizu Y, Shimizu N. Protein kinase C phosphorylates DNA topoisomerase I. FEBS Lett. 259:1989;57-60.
60. Pommier Y, Kerrigan D, Hartman K D. Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C. J Biol Chem. 265:1990;9418-9422.
61. Tournier M F, Sobczak J, de Nechaud B. Comparison of biochemical properties of DNA-topoisomerase I from normal and regenerating liver. Eur J Biochem. 210:1992;359-364.
62. D'Arpa P, Liu L F. Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I. Exp Cell Res. 217:1995;125-131.
63. Krupitza G, Cerutti P. ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. Biochemistry. 28:1989;2034-2040.
64. Boothman D A, Fukunaga N, Wang M. Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res. 54:1994;4618-4626.
65. Ferro A M, Higgins N P, Olivera B M. Poly(ADP-ribosylation) of a DNA topoisomerase. J Biol Chem. 258:1983;6000-6003.
66. Jongstra-Bilen J, Ittel M E, Niedergang C. DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation). Eur J Biochem. 136:1983;391-396.
67. Kasid U N, Halligan B, Liu L F. Poly(ADP-ribose)-mediated post-translational modification of chromatin-associated human topoisomerase I. Inhibitory effects on catalytic activity. J Biol Chem. 264:1989;18687-18692.
68. Adamietz P. Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. Eur J Biochem. 169:1987;365-372.
69. Ferro A M, Olivera B M. Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. J Biol Chem. 259:1984;547-554.
70. Javaherian K, Liu L F. Association of eukaryotic DNA topoisomerase I with nucleosomes and chromosomal proteins. Nucleic Acids Res. 11:1983;461-472.
71. Rose K M, Szopa J, Han F S. Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Chromosoma. 96:1988;411-416.
72. Bharti A K, Olson M O, Kufe D W. Identification of a nucleolin binding site in human topoisomerase I. J Biol Chem. 271:1996;1993-1997.
73. Kordiyak G J, Jakes S, Ingebritsen T S. Casein kinase II stimulates Xenopus laevis DNA topoisomerase I by physical association. Biochemistry. 33:1994;13484-13491.
74. Gobert C, Bracco L, Rossi F. Modulation of DNA topoisomerase I activity by p53. Biochemistry. 35:1996;5778-5786.
75. Albor A, Kaku S, Kulesz-Martin M. Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants. Cancer Res. 58:1998;2091-2094.
76. Larsen A K, Gobert C, Gilbert C. DNA topoisomerases as repair enzymes: Mechanism(s) of action and regulation by p53. Acta Biochim Pol. 45:1998;535-544.
77. Gobert C, Skaldanowski A, Larsen A K. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc Natl Acad Sci USA, in press. 1999.
78. Mc Leod H L, Douglas F, Oates M. Topoisomerase I and II activity in human breast, cervix, lung and colon cancer. Int J Cancer. 59:1994;607-611.
79. Vassal G, Pondarré C, Cappelli C. DNA topoisomerase I, a new target for the treatment of neuroblastoma. Eur J Cancer. 33:1997;2011-2015.
80. Husain I, Mohler J L, Seigler H. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 54:1994;539-546.
81. Giovanella B C, Steblin J S, Wall M E. DNA topoisomerase I targeted chemotherapy of human colon cancer in xenografs. Science. 246:1989;1046-1048.
82. Lynch B J, Komaromy-Hiller G, Bronstein I B. Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma. Hum Pathol. 29:1998;1240-1245.
83. McLeod H L, Keith W N. Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity. Br J Cancer. 74:1996;508-512.
84. Liu L F, Desai S D, Wu J X. The roles of ubiquitin-dependent proteolysis in determining the sensitivity/resistance of tumor cells to topoisomerase inhibitors. Proc Am Ass Cancer Res. 40:1999;775-775.
85. Larsen A K, Skladanowski A. Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death. Biochem Biophys Acta. 1400:1998;257-274.